CBS 2019
CBSMD教育中心
English

Percutaneous LAA Occlusion

科研文章

荐读文献

2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation: Results From the International Multi-Center Feasibility Trials Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study
|<< 1 2 >>|

Guideline2015 Sep 29;66(13):1497-513.

JOURNAL:J Am Coll Cardiol. Article Link

2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview

Masoudi FA, Calkins H, Kavinsky CJ. Keywords: ACC/HRS/SCAI Societal Overview; atrial fibrillation; left atrial appendage; prevention; stroke

FULL TEXT PDF